By Memorial Sloan Kettering | Tuesday, July 31, 2012
Watch urologic surgeon Karim Touijer discuss our comprehensive approach to cancer care and recent advances in minimally invasive surgery.
By Memorial Sloan Kettering | Friday, July 13, 2012
Earlier this year, a surgical team from Memorial Sloan Kettering participated in an example of international collaboration at its finest: an educational outreach mission to Costa Rica.
In the O.R.
By Jim Stallard, MA, Writer/Editor | Monday, July 9, 2012
Memorial Sloan Kettering surgeons have pioneered a technique that may improve quality of life for women with early-stage gynecologic cancers.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, July 6, 2012
A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
By Memorial Sloan Kettering | Monday, June 25, 2012
Dr. Morrow, Chief of Memorial Sloan Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.
By Memorial Sloan Kettering | Friday, June 15, 2012
Dr. Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.
In the News
By Media Staff | Tuesday, June 12, 2012
The magazine’s 15th annual issue recognizes more cancer physicians from Memorial Sloan Kettering than any other hospital.
By Memorial Sloan Kettering | Thursday, June 7, 2012
Dr. Allen talks about the specialized team of cancer experts at Memorial Sloan Kettering and the long-term relationships he maintains with his patients.
In the Clinic
By Media Staff | Monday, June 4, 2012
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.
By Memorial Sloan Kettering | Friday, June 1, 2012
Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.
By Memorial Sloan Kettering | Tuesday, May 29, 2012
Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.
By Allyson Collins, MS, Science Writer/Editor | Monday, May 21, 2012
In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan Kettering | Monday, May 14, 2012
Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.